Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine
Overview
Authors
Affiliations
Long-acting injectable antiretroviral medications are new to HIV treatment. People with HIV may benefit from a treatment option that better aligns with their preferences, but could also face new challenges and barriers. Authors from the fields of HIV, substance use treatment, and mental health collaborated on this commentary on the issues surrounding equitable implementation and uptake of LAI ART by drawing lessons from all three fields. We employ a socio-ecological framework beginning at the policy level and moving through the community, organizational, interpersonal, and patient levels. We look at extant literature on the topic as well as draw from the direct experience of our clinician-authors.
Bunting S, Feinstein B, Vidyasagar N, Wilson A, Schneider J, Ehsan D Psychiatr Res Clin Pract. 2024; 6(4):151-163.
PMID: 39669536 PMC: 11633549. DOI: 10.1176/appi.prcp.20240069.
HIV vaccination: Navigating the path to a transformative breakthrough-A review of current evidence.
Scott G, Worku D Health Sci Rep. 2024; 7(9):e70089.
PMID: 39319247 PMC: 11420300. DOI: 10.1002/hsr2.70089.
Haser G, Balter L, Gurley S, Thomas M, Murphy T, Sumitani J AIDS Res Hum Retroviruses. 2024; 40(12):690-700.
PMID: 38959116 PMC: 11807906. DOI: 10.1089/AID.2024.0007.
Manghani P, Monroe A, Castel A, Kumar P, Phunmongkol J, Denyer R Open Forum Infect Dis. 2024; 11(5):ofae087.
PMID: 38756764 PMC: 11097117. DOI: 10.1093/ofid/ofae087.
Fisk-Hoffman R, Ranger S, Gracy A, Gracy H, Manavalan P, Widmeyer M AIDS Patient Care STDS. 2024; 38(6):275-285.
PMID: 38686517 PMC: 11301705. DOI: 10.1089/apc.2024.0067.